new fda ruling on tirzepatide Breaking News: Compounding Pharmacies Take the Fight to the Fifth Circuit The Outsourcing Facilities Association (OFA) has filed an appeal challenging the FDA's decision to restrict compounding pharmacies from producing tirzepatide, the Is Tirzepatide Legal in 2026?

Future of Incretin Therapy The remarkable success of Tirzepatide has validated the multi-agonist approach to treating metabolic diseases

The FDA recently approved tirzepatide for treatment of obstructive sleep apnea, which occurs when a person stops breathing while sleeping

This finding suggests that semaglutide does not cause insomnia, since the inactive placebo treatment group had the same experience with sleep.\ Still, rumors about Ozempic insomnia have circulated on social media channels like TikTok, Facebook, and Reddit

Whilst headaches are generally not considered a defining characteristic of tirzepatide therapy, they can affect quality of life and treatment adherence for some individuals

Tinnitus can be broken down into two major types: pulsatile and non-pulsatile